 | Up a level |
Journal Article
Ataseven, B., Rhiem, K., Staniczok, C., Heitz, F., Pauly, N., Moubarak, M., Concin, N., Traut, A., Schmutzler, R. and Harter, P. (2022). Prevalence and oncological outcome of patients with primary epithelial ovarian cancer (EOC) carrying gene mutations or variants of unknown signifikance (VUS) detected by germline gene panel testing. Geburtshilfe Frauenheilkd., 82 (10). S. E44 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Ataseven, B., Tripon, D., Schwameis, R., Harter, P., Rhiem, K., Schneider, S., Heikaus, S., Baert, T., Alesina, P., Heitz, F., Traut, A., Groeben, H. T., Schmutzler, R. and du Bois, A. (2021). Impact of BRCA1/2 Germline Status on intraperitoneal Tumor Distribution, Operability, and Incidence of postoperative Complications in Patients with epithelial Ovarian Cancer. Geburtshilfe Frauenheilkd., 81 (4). S. E2 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Belau, A., du Bois, A., Sehouli, J., Reuss, A., Lampe, B., Meier, W., Stuth, R., Forner, D. M., Elling, D., Denschlag, D., Pfisterer, J., Gnauert, K., Armin, B., von Koch, F. E., Valter, M., Mahner, S., Runnebaum, I. B., Schmalfeldt, B., Wagner, U. and Harter, P. (2018). lion-lymphadenectomy in ovarian neoplasms.a prospective randomized ago study group led gynecologyc cancer intergroup trial. Oncol. Res. Treat., 41. S. 13 - 14. BASEL: KARGER. ISSN 2296-5262
Denschlag, D., Thiel, F. C., Ackermann, S., Harter, P., Juhasz-Boess, I., Mallmann, P., Strauss, H. -G., Ullrich, U., Horn, L. -C., Schmidt, D., Vordermark, D., Vogl, T., Reichardt, P., Gass, P., Gebhardt, M. and Beckmann, M. W. (2015). Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). Geburtshilfe Frauenheilkd., 75 (10). S. 1028 - 1041. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Harter, P., Baumann, K., Heimbach, A., Reuss, A., Jackisch, C., Hauke, J., Park-Simon, T. W., Richters, L., Hanker, L., Kroeber, S., Pfisterer, J., Gevensleben, H., Schnelzer, A., Dietrich, D., Schneider, S., Kommoss, S., Marme, F., Prieske, K., Schmutzler, R. and Hahnen, E. (2016). Mutations of risk genes for ovarian cancer in consecutive ovarian cancer patients (AGO TR-1 study). Int. J. Gynecol. Cancer, 26. S. 81 - 83. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1525-1438
Hauke, J., Hahnen, E., Burges, A., Reuss, A., Gregorio, N. D., El-Balat, A., Richters, L., Hilpert, F., Schmidt, S., Meier, W., Gevensleben, H., Heubner, M., Dietrich, D., Kast, K., Braicu, E., Neunhoeffer, T., Schmutzler, R. K. and Harter, P. (2018). Prevalence of somatic mutations in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1 study). Oncol. Res. Treat., 41. S. 90 - 92. BASEL: KARGER. ISSN 2296-5262
Heitz, F., Ataseven, B., Moubarak, M., Staniczok, C., Schmutzler, R., Schameis, R., Heikaus, S., Concin, N., Riehm, K., Denkert, C. and Harter, P. (2022). HRD Testing and BRCA1/2 Germline Testing in Routine Clinical Practice in Patients with primary Ovarian Cancer. Geburtshilfe Frauenheilkd., 82 (10). S. E86 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Heitz, F., Weber-Lassalle, K., Ernst, C., Moellenhoff, K., De Gregorio, N., Hauke, J., Dietrich, D., Borde, J., Jackisch, C., Park-Simon, T-W, Hanker, L. C., Pohl-Rescigno, E., Prieske, K., Kommoss, S., Marme, F., Stingl, J. C., Rita, S., Harter, P. and Hahnen, E. (2022). Chemotherapy-induced mutations in genes of clonal hematopoiesis increase the risk of myeloid neoplasms. Geburtshilfe Frauenheilkd., 82 (10). S. E88 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Hillemanns, P., Woelber, L., Jueckstock, J., Neuser, P., Hilpert, F., Harter, P., De Gregorio, N., Hasenburg, A., Sehouli, J., Habermann, A., Fuerst, S. T., Strauss, H. -G., Baumann, K., Thiel, F., Mustea, A., Meier, W., Du Bois, A., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Richter, B., Petersen, C. and Mahner, S. (2014). AGO Vulva CaRE-1 multicenter study - adjuvant radio(chemo)therapy in vulvar cancer. Oncol. Res. Treat., 37. S. 70 - 71. BASEL: KARGER. ISSN 2296-5262
Holly, J., Harter, P., Ataseven, B., Moubarak, M., Schwameis, R., Heikaus, S., Concin, N., Rhiem, K., Denkert, C. and Heitz, F. (2022). HRD Testing and BRCA1/2 Germline Testing in routine clinical Practice in Female Patients with primary Ovarian Cancer. Geburtshilfe Frauenheilkd., 82 (4). S. E5 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Imterat, M., du Bois, A., Harter, P., Rhiem, K., Heitz, F., Concin, N., Traut, A., Schmutzler, R. and Ataseven, B. (2022). Incidence and prognostic impact of pathogenic germline mutations in gene panel testing of primary advanced epithelial ovarian cancer patients. Geburtshilfe Frauenheilkd., 82 (10). S. E97 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Jueckstock, J., Fuerst, S., Bommert, M., Harter, P., Prieske, K., Eulenburg, C., Hilpert, F., deGregorio, N., Iborra, S., Sehouli, J., Ignatov, A., Hillemanns, P., Jaeger, A., Strauss, H-G, Baumann, K., Thiel, F., Mustea, A., Meier, W., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Woelber, L. and Mahner, S. (2020). Importance of pelvic Lymphonodectomy in Squamous Cell Carcinoma of the Vulva (VSCC) Subgroup Analysis of the AGO-CaRE-1 Study. Geburtshilfe Frauenheilkd., 80 (7). S. 740 - 741. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Marme, F., Harter, P., Hauke, J., Heitz, F., Reuss, A., Kommoss, S., Heimbach, A., Prieske, K., Richters, L., Burges, A., Neidhardt, G., de Gregorio, N., El-Balat, A., Hilpert, F., Meier, W., Heubner, M., Kast, K., Braicu, I., Hahnen, E. and Schmutzler, R. (2016). Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1). Int. J. Gynecol. Cancer, 26. S. 194 - 196. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1525-1438
Neupert, L. -M., May, P., Kobow, K., Nothnagel, M. 
ORCID: 0000-0001-8305-7114, Nuernberg, P., Freiman, T., Harter, P., Klein, K. M., Weber, Y., Bluemcke, I. and Lal, D.
(2017).
DISCOVERY AND PATHOGENICITY ASSESSMENT OF NEUROPATHOLOGY-ASSOCIATED GENE VARIANTS.
Epilepsia, 58.
S. S174 - 1.
HOBOKEN:
WILEY.
ISSN 1528-1167
Pauly, N., Harter, P., Heitz, F., Schoemig-Markiefka, B., Moubarak, M., Traut, A., Kaiser, S. and Ataseven, B. (2022). MLH1 promoter hypermethylation in mismatch repair deficient endometrial cancer.Defining a new subgroup? Geburtshilfe Frauenheilkd., 82 (10). S. E138 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Prieske, K., Woelber, L., Muallem, M. Z., Eulenburg, C., Jueckstock, J., Hilpert, F., de Gregorio, N., Iborra, S., Ignatov, A., Hillemanns, P., Fuerst, S. T., Strauss, H. G., Baumann, K., Thiel, F., Mustea, A., Meier, W., Harter, P., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Sehouli, J. and Mahner, S. (2020). The influence of age on treatment and prognosis of patients with squamous cell vulvar cancer (VSCC)- a subset analysis of the AGO-CaRE-1 study. Geburtshilfe Frauenheilkd., 80 (10). S. E201 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Richters, L., Schouten, P. C., Park-Simon, T-W., Hauke, J., Hanker, L., Dietrich, D., Pfisterer, J., Krockenberger, M., Kluin, R., Schnelzer, A., du Bois, A., Kommoss, S., Heimbach, A., Schmidt, S., Marme, F., Prieske, K., Linn, S. C., Schmutzler, R. K., Harter, P. and Hahnen, E. (2018). BRCA-like classification in ovarian cancer - Results from the AGO-TR1-trial. Oncol. Res. Treat., 41. S. 85 - 86. BASEL: KARGER. ISSN 2296-5262
Sehouli, J., Mahner, S., Neunhoeffer, T., Harter, P., de Gregorio, N., Fridrich, C., Markmann, S., Richter, R., Potenberg, J., Lorenz, R., Schmidt, M., Doering, G., Belau, A., Lueck, H. J., Chekerov, R., du Bois, A. and Hilpert, F. (2016). Topotecan (T) +/- Sorafenib (S) for platinum-resistant ovarian cancer (PROC): results of doubleblind placebo-controlled randomized NOGGO - AGO intergroup trial. Int. J. Gynecol. Cancer, 26. S. 2 - 4. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1525-1438
Staniczok, C., Ataseven, B., Heitz, F., Harter, P., Rhiem, K., Pauly, N., Traut, A. and Moubarak, M. (2022). Prevalence and clinical characterization of concurrent multiple deleterious germline mutations in German patients with epithelial ovarian cancer. Geburtshilfe Frauenheilkd., 82 (10). S. E165 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Vergote, I, Gonzalez-Martin, A., Ray-Coquard, I, Harter, P., Colombo, N., Pujol, P., Lorusso, D., Mirza, M. R., Brasiuniene, B., Madry, R., Brenton, J. D., Ausems, M. G. E. M., Buettner, R. and Lambrechts, D. (2022). European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer. Ann. Oncol., 33 (3). S. 276 - 288. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Woelber, L., Jueckstock, J., Hilpert, F., Neuser, P., Harter, P., De Gregorio, N., Iborra, S., Sehouli, J., Habermann, A., Hillemanns, P., Fuerst, S., Strauss, H. -G., Baumann, K. H., Thiel, F., Mustea, A., Meier, W., Du Bois, A., Wimberger, P., Hanker, L. C., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Richter, B., Griebel, L. -F. and Mahner, S. (2014). Outcome parameters in node-negative vulvar cancer - subset analysis of the AGO CaRE-1 study. Oncol. Res. Treat., 37. S. 72 - 74. BASEL: KARGER. ISSN 2296-5262